An investigative reporter wrote a very interesting article

New Post Public Reply Private Reply Replies (1) Message Board
Enjay
1,170
An investigative reporter wrote a very interesting article on the FDA and Ivermectin. I am posting this so you can see what the reporter turned up about the FDA, not Ivermectin. The article was published on rescue.substack.com and I will post a link to the article below. I am not familiar with that website, but the FOIA emails look authentic. The article is rather long, but I hope the excerpts I am posting below entice you to read the entire article at the link.

In a hokey tweet on August 21, the U.S. Food and Drug Administration told Americans the obvious: “You are not a horse. You are not a cow. Seriously, y’all. Stop it.”
Everyone knew what “it” was: an animal form of the drug ivermectin that folks were said to be using, widely, for covid-19. Don’t, said FDA.

Within two days, 23.7 million people had seen that Pulitzer-worthy bit of Twitter talk. Hundreds of thousands more got the message on Facebook, LinkedIn, and from the Today Show’s 3 million-follower Instagram account.

There was one problem, however. The tweet was a direct outgrowth of wrong data—call it misinformation—put out the day before by the Mississippi health department. The FDA did not vet the data, according to our review of emails obtained under the Freedom of Information Act and questions to FDA officials. Instead, it saw Mississippi, as one email said, as “an opportunity to remind the public of our own warnings for ivermectin.”

It began with one sentence in a Mississippi health alert on reports to the state’s poison control center: “At least 70% of the recent calls have been related to ingestion of livestock or animal formulations of ivermectin purchased at livestock supply centers.” In the thick of a fierce covid wave in the American South, no official at the FDA, or reporter for that matter, seemed to ask: 70 percent of what? Instead, government and media joined forces against a public health threat that, in retrospect, was vastly exaggerated.

Amid dozens of articles that ensued, Rolling Stone told of Oklahoma hospitals so jammed with ivermectin overdoses that gunshot victims had to wait for care—except it wasn’t true. Twice, The New York Times printed corrections of the same false information from Mississippi, which it described in one article and later removed, as “a staggering number of calls.” The Associated Press, Washington Post and, twice, the The Guardian in London also corrected its reporting on the alert.

The Times’ correction summed it up: “This article misstated the percentage of recent calls to the Mississippi poison control center related to ivermectin. It was 2 percent, not 70 percent.” (The Times and Post both made corrections in direct response to our reporting for this article.)
In real numbers, six calls were received for ingestion of ivermectin. Four were for the antiparasitic drug given to livestock.

So how big was the surge that FDA described as “multiple”? Four, an agency spokesperson said just after the page went up. Three people were hospitalized, but it wasn’t clear if that was for covid itself. When pressed for details, FDA cited privacy issues, and said in an email, “Some of these cases were lost to follow up.”
This is how government gets away with some whoppers, and with the media’s help.

Below, FDA officials crow over the deception that was “the most popular post we’ve ever had on Twitter:”

1811865471_FDA(Erica)8-23-21email.png

…and the FDA commissioner was thrilled:

1058964438_Woodcockemail.png

In this email obtained by Linda Bonvie under the Freedom of Information Act, FDA officials celebrate reaching the “everyday” American with a tweet that sparked a media firestorm of lies:

346533143_FDA(Erica)8-22-21email.png

Here is the link for the entire article:
https://rescue.substack.com/p/horse-bleep-how...-on-animal

Here is the FDA's bio for Erica Jefferson, Associate Commissioner for External Affairs.
https://www.fda.gov/about-fda/fda-organizatio...-jefferson

Interesting follow-up note: Mary Beth Pfeiffer, the investigative journalist who wrote the article, was locked out of Twitter for violating their rules one day after the article appeared. She was gaining lots of new followers until the lockout.
https://rescue.substack.com/p/a-day-after-our...tm_source=

So many interesting points could be made about this. Here are the first few I thought about:

The FDA has an External Affairs Department ready to move quickly, even on erroneous data.

The FDA tracks number of hits on tweets and new followers.

Now think about their unsigned hit-piece on Leronlimab. I wonder if they also counted the hits on that one and then celebrated?

I know I am "preaching to the choir" about the FDA, but the FOIA emails are (pick one or use your own): amazing - astounding - appalling - disappointing....................................

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Adecoagro Hits Record EBITDA Amid Rain Challenges

Updated Category News Views 149

Adecoagro Breaks Records Despite Hurdles Picture this: Adecoagro's financials rolling in like a freight train, with nine-month adjusted EBITDA hitting an unprecedented $471.8 million. But hold on, it wasn't all smooth sailing. That kind of growth often comes with its own set of challenges, and this round wasn't any different for the South American agricultural...

Continue Reading
Nikon Lenswear: Celebrates 80 Years of Vision Innovations

Updated Category News Views 38

From a Single Lens to a Vision Empire Not many realize how far the optical world has come since 1946. That was the year when Nikon kicked off its journey with the Pointal Lens, a humble spectacle lens hoping to do one thing—help folks see better. Fast forward 80 years, and Nikon Lenswear ain't just about seeing clearly. It's about seeing the world through a lens...

Continue Reading
Curve Dental Pushes Dental Tech with New Marketing Head

Updated Category News Views 41

Curve Dental's Bold Move in Dental Technology Nat Harrison stepping up as Senior VP of Marketing at Curve Dental seems like a big swing for a firm already in the thick of reshaping dental practice management. Curve Dental's advancing platform boasts AI-powered, cloud-native capabilities that aim to streamline operations for dental teams stretched thin by daily demands....

Continue Reading
Allegiant, Bank of America Extend Credit Card Deal

Updated Category News Views 68

Allegiant and Bank of America: A Decade of Partnership Picture Allegiant Travel Company (NASDAQ: ALGT) and Bank of America (NYSE: BAC) shaking hands over a table that's seen ten years of successful collaboration. They're not just renewing vows; they're doubling down, announcing a long-term extension of their co-branded credit card partnership. In a world where loyalty...

Continue Reading
Tyson & Mendes Expands into Carolinas with Strategy

Updated Category News Views 109

Tyson & Mendes: A Strategic Move into the Carolinas The legal arena's always a battleground, and Tyson & Mendes just pulled off a strategic maneuver by expanding into North and South Carolina. This ain't just another firm opening more doors; it's a calculated move to fortify their defense against those monstrous Nuclear Verdicts®. You know the ones—those court...

Continue Reading
Voyageurs Park Honors Dark Skies with 2026 Recognition

Updated Category News Views 82

Voyageurs' Skyward Triumph: A Stellar Win for Conservation Ah, the night sky. That vast, galaxy-speckled canvas we too often ignore, drowned out by urban light pollution. But hey, not in Voyageurs National Park, no sir. This gem's just snagged the 2026 International Dark Sky Place of the Year Award, handed out by those watchful folks at DarkSky International. It's a...

Continue Reading
Greenland Energy's Bold Move: A Stake in East Greenland

Updated Category News Views 0

A Familiar Energy Terrain Shifts When Greenland Energy Company (NASDAQ:GLND) threw down the gauntlet by announcing their maneuver to scoop up 80 Mile plc, it wasn't just another day in the boardroom. It's a classic case of one strong entity eyeing consolidation to drill deeper, not just in the wells, but into the market psyche. The proposed all-share acquisition paves the...

Continue Reading
Laekna: LAE124 Poised for Obesity Week Spotlight

Updated Category News Views 20

LAE124 Could Shake Up Obesity Treatment Norms Just roll the dice on innovation sometimes, because that's when you get a spark. Laekna, a name you’ve heard in biotech circles, is gearing up to showcase LAE124 at Obesity Week 2026. This ain't just another weight-loss compound tossed into the market. We're talking about a new small-molecule dual Amylin/Calcitonin receptor...

Continue Reading
Stegra and Meta Forge Alliance for Green Steel EAC

Updated Category News Views 89

Meta Bets on Green Steel's Future Out of left field, we've got Meta cozying up to Stegra in a pretty big way. They just inked a deal for environmental attribute certificates (EACs) that could shake up the steel industry. These two players are coming together to embrace something that's still piping hot and fresh off the press: sustainable steel. Stegra, still in its...

Continue Reading
West Virginia's Small Biz Insurance: Risks and Rewards

Updated Category News Views 72

Insurance: More Than a Safety Net Rolling through Bluefield, West Virginia, you spot these humble small businesses propping up the local spirit—more than just storefronts, they’re the town's heartbeat. But, like any heartbeat, it’s vulnerable to a bunch of risks. That's where insurance steps in, like a cloak of safety keeping the vitals secure. Now, it’s not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Outset Medical Successfully Resolves FDA Warning Letter Issues

Updated Category News Views 126

Outset Medical Resolves Important Regulatory Issues Outset Medical, Inc. (NASDAQ: OM), a leading innovator in medical technologies for dialysis, recently announced significant progress in addressing the issues outlined in a Warning Letter from the Food and Drug Administration (FDA). This notification reflects Outset's commitment to high standards and continuous...

Continue Reading
Insightful Update on Man Group PLC's Disclosure Position

Updated Category News Views 199

Man Group PLC's Public Opening Position Disclosure FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE UNDER RULE 8.3 OF THE TAKEOVER CODE Key Information 1. Key Details (a) Full name of discloser: Man Group PLC (b) Owner or controller of interests and short positions disclosed, if

Continue Reading
Seneca Foods Corp (B) Achieves Significant Stock Milestone

Updated Category News Views 176

Seneca Foods Corp (B) Reaches New Stock Heights Seneca Foods Corp (B) has recently achieved a remarkable milestone, peaking at an all-time high of $80.97. This significant achievement marks a notable chapter in the company's journey, emphasizing a period of impressive growth. Over the past year, Seneca's stock value has surged by an impressive 52.65%, showcasing not just...

Continue Reading
Elevate Your Home Security This Winter with Smart Technology

Updated Category News Views 136

Embracing Smart Technology for Winter Home Protection Local HVAC, Plumbing, and Electrical Experts Recommend Smart Leak Detectors, Thermostats, and Security Systems for Comprehensive Home Protection As winter approaches, homeowners must prepare for the challenges that come with the season. Vander Hyde Services, a trusted name in home services, emphasizes the importance of...

Continue Reading
Revolutionizing Weddings: The Path to Inclusivity and Diversity

Updated Category News Views 248

Revolutionizing Weddings with the Inclusive Wedding Summit The Inclusive Wedding Summit is set to reshape the landscape of wedding planning and marketing by focusing on inclusivity and diversity. This trailblazing event will bring together wedding professionals, industry experts, and marketing specialists seeking to embrace these important themes on January 22, 2025. As...

Continue Reading